May 2009
A Facile Electrochemical Method for the Synthesis of 5-Phenyl-1,3,4-oxadiazol-
2-ylthio-benzene-1,2-diol Derivatives
445
Scheme 1. Proposed mechanism for the electrooxidation of catechols in the presence of 5-phenyl-1,3,4-oxadiazole-2-thiol (3). [Color figure can be
viewed in the online issue, which is available at www.interscience.wiley.com.]
3
3-methylcatechol was reagent-grade from Acros. These chemi-
cals were used without further purification. All experiments
were carried out at room temperature.
3.74 (s, 3H, OCH3), 3.78 (s, 3H, OCH3), 6.68 (d, JHH ¼ 8.40
Hz, 1H, CH), 6.80 (s, 1H, CH), 6.83 (s, 1H, CH), 6.98 (d,
3JHH ¼ 8.40 Hz, 1H, CH), 7.56 (m, 6H, CH), 7.87 (m, 4H,
CH), 9.34 (broad, 4H, OH). 13C NMR (75 MHz, DMSO-d6) d
(ppm): 56.59, 61.00, 108.67, 110.03, 112.28, 113.76, 115.55,
123.42, 125.69, 126.72, 126.80, 129.91, 132.56, 137.03,
139.92, 146.91, 149.27, 150.32, 163.66, 165.62, 165.91. MS
(70 eV) m/z (relative intensity): 317 (20), 178 (40), 140 (100),
97 (50), 77 (75), 43 (60).
Electroorganic synthesis of products. In a typical proce-
dure, 100 mL mixture of water/acetonitrile (95/5) containing
phosphates (KH2PO4/K2HPO4) as the buffer and supporting
electrolyte (pH 7.2, C ¼ 0.15M) was preelectrolyzed at the
potential mentioned in Table 2 in an undivided cell. Subse-
quently, 2 mmol of catechols (1a–d) and 2 mmol of nucleo-
phile (3) were added to the cell. Finally, the electrolysis was
performed at the same potential.
The electrolysis was terminated when the decay of the current
became more than 95%. The process was interrupted several
times during the electrolysis and the carbon anode was washed
in acetone to reactivate it. At the end of electrolysis, the cell was
placed in a refrigerator overnight. The precipitated solid was col-
lected by filtration and then was washed several times with dis-
tilled water. After purification, products were characterized using
IR, 1H NMR, 13C NMR, X-ray, and Mass spectral data.
5-(5-Phenyl-1,3,4-oxadiazol-2-ylthio)-3-methylbenzene-1,2-
diol (4d). m.p. 180–181ꢂC. IR (KBr) m (cmꢁ1): 3062, 2924,
1591, 1550, 1514, 1471, 1414, 1349, 1266, 1189. 1H NMR
(300 MHz, DMSO-d6) d (ppm): 2.12 (s, 3H, CH3), 6.94 (br s,
2H, CH), 7.59 (m, 3H, CH), 7.88 (m, 2H, CH), 8.91 (broad,
1H, OH), 9.77 (broad, 1H, OH). 13C NMR (75 MHz, DMSO-
d6) d (ppm):16.26, 113.40, 118.94, 123.42, 126.50, 126.84,
127.77, 129.94, 132.59, 146.08, 146.28, 163.88, 165.90. MS
(70 eV) m/z (relative intensity): 300 (30), 178 (32), 145 (75),
124 (36), 77 (100), 51 (48).
Characteristics of the products. 4-(5-Phenyl-1,3,4-oxa-
diazol-2-ylthio)-5-methylbenzene-1,2-diol (4a). m.p. 205–
207ꢂC. IR (KBr) m (cmꢁ1): 3443, 2924, 1709, 1608, 1583,
4-(5-Phenyl-1,3,4-oxadiazol-2-ylthio)-3-methylbenzene-1,2-
diol (40d). m.p.178–180ꢂC. IR (KBr) m (cmꢁ1): 3077, 2660,
1608, 1552, 1479, 1353, 1290, 1213, 1178. 1H NMR (300
1
3
1555, 1472, 1420, 1364, 1292, 1224, 1197. H NMR (300 MHz,
MHz, DMSO-d6) d (ppm): 2.28 (s, 3H, CH3), 6.75 (d, JHH
¼
3
DMSO-d6) d (ppm): 2.29 (s, 3H, CH3), 6.81 (s, 1H, CH), 7.07
(s, 1H, CH), 7.58 (m, 3H, CH), 7.87 (m, 2H, CH), 9.42 (broad,
2H, OH). 13C NMR (75 MHz, DMSO-d6) d (ppm): 20.08,
113.00, 118.55, 123.08, 123.43, 126.76, 129.90, 132.50, 133.80,
144.55, 148.63, 163.71, 165.76. MS (70 eV) m/z (relative inten-
sity): 301 (5), 178 (30), 145 (30), 124 (63), 77 (100), 39 (60).
4-(5-Phenyl-1,3,4-oxadiazol-2-ylthio)benzene-1,2-diol (4b).
m.p. 164–166ꢂC. IR (KBr) m (cmꢁ1): 3447, 2924, 1603, 1550,
1477, 1434, 1358, 1277, 1253, 1187, 1150. 1H NMR (300
8.29 Hz, 1H, CH), 7.07 (d, JHH ¼ 8.29 Hz, 1H, CH), 7.56
(m, 3H, CH), 7.87 (m, 2H, CH), 8.74 (broad, 1H, OH), 9.98
(brod, 1H, OH). 13C NMR (75 MHz, DMSO-d6) d (ppm):
14.52, 113.83, 114.46, 126.82, 127.83, 129.62, 132.47, 132.56,
144.95, 148.22, 165.67, 165.89. MS (70 eV) m/z (relative
intensity): 300 (22), 178 (38), 124 (42), 77 (100), 39 (43).
Crystal data for (40d) C15H12N2O3S1, Mw ¼ 300.34: space
˚
group monoclinic, P21/a, a ¼ 8.3924(6) A, b ¼ 18.4381(15)
ꢁ3
˚
ꢂ
˚
˚
A, c ¼ 9.7245(6) A, b ¼ 111.713(5) , V ¼ 1398.00(17) A
:
3
MHz, DMSO-d6) d (ppm): 6.84 (d, JHH ¼ 8.22 Hz, 1H, CH),
3
7.01 (d, JHH ¼ 8.22 Hz, 1H, CH), 7.07 (s, 1H, CH), 7.57 (m,
3H, CH), 7.88 (m, 2H, CH), 9.62 (broad, 2H, OH). 13C NMR
(75 MHz, DMSO-d6) d (ppm): 114.21, 117.10, 121.64, 123.40,
126.51, 126.81, 129.91, 132.57, 146.76, 148.34, 163.83,
165.88. MS (70 eV) m/z (relative intensity): 287 (10), 178
(55), 145 (30), 110 (70), 77 (100), 51 (55).
Table 2
Applied potentials for the synthesis of products.
Applied potential (V) vs.
Ag|AgCl|KCl (3M)
Conversion
Mixture of 5-(5-phenyl-1,3,4-oxadiazol-2-ylthio)-3-meth-
oxybenzene-1,2-diol (4c) 4-(5-phenyl-1,3,4-oxadiazol-2-yl-
thio)-3-methoxybenzene-1,2-diol (40c). m.p. 175–178ꢂC. IR
(KBr) m (cmꢁ1): 3367, 2937, 1600, 1551, 1503, 1472, 1341,
1293, 1196, 1088. 1H NMR (300 MHz, DMSO-d6) d (ppm):
1a ! 4a
0.15
0.2
1b ! 4b
1c ! (4c:40c)
1d ! (4d:40d)
0.10
0.15
Journal of Heterocyclic Chemistry
DOI 10.1002/jhet